Medical research

‘Too good to be true’: A Chinese study on timing cancer therapy is retracted

Those who received IV infusions in the morning had their cancer kept at bay for twice as long as those who got it in the afternoon, according to the study.

3 friends raise over $44,000 for cancer research by running relay for 10 days in China

(From left) Jensen Jing, Ryan Tay, and Timothy Foo, who raised $44,500 for cancer research in a 10-day relay run through China.

The proof is in the poo: S’pore study links gut health to fatty liver disease

NTU-LKCMedicine researchers Damien Chua, a doctorate student (left), and Associate Professor Andrew Tan, the Provost's Chair in Metabolic Disorder at LKCMedicine, found a protein in stool that links diet, gut bacteria, and liver health. It could help prevent the early stages of fatty liver disease.

Five volunteers given weakened dengue virus in study to help develop treatments and vaccines

Between March and May 2026, the participants received a weakened strain of the DENV-3 serotype of the dengue virus.

A blood test may help detect Alzheimer’s disease years before cognitive symptoms appear

ST20240821_202409200185/pixgeneric/Jason Quah
Generic pix of an elderly couple on a bus on 21 Aug, 2024.
ageing, population, old,

‘It’s still working’: More are living with cancer as era of targeted drugs takes hold

Menta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.

Covid-19 pandemic left 55,000 cancer cases undiagnosed across 7 nations, study finds

An estimated 16 per cent of expected cancer diagnoses across Australia, Canada, Denmark, Ireland, New Zealand, Norway and Britain were missing between April and December 2020.

J&J drug Erleada reduces risk of prostate cancer spread, death

Prostrate cancer patients who were on Erleada and hormone-blocking therapy went more than six years before requiring subsequent treatment.

Lung cancer patients on drug from China’s Akeso lived longer

The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.